VolitionRx Limited (VNRX)

Every figure this model derived for VNRX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 21,969 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 2,800,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 4,092,944 AssetsCurrent 2026-06-30
current liabilities 13,492,636 LiabilitiesCurrent 2026-06-30
equity -32,164,943 StockholdersEquity 2026-06-30
interest expense 866,230 InterestExpenseNonoperating 2026-06-30
ocf -19,562,408 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 2,458,044 Revenues 2026-06-30
sbc 1,739,711 ShareBasedCompensation 2025-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up VNRX on one particular measure came for.

RatioValue
cash operating margin-683.88
current ratio0.31
current ratio reported0.3
deferred revenue growth-22.71
dilution pct23.48
fcf margin-796.75
growth cv0.91
interest cover-22.42
operating margin-790.23
owner earnings margin-867.52
revenue growth86.32
revenue growth per share50.89
rule of 40-703.91
sbc pct revenue70.78

What to be careful about

What this model itself distrusts about VNRX's figures. Written by the derivation as it ran, not added afterwards.